共 38 条
[1]
ANDERSON JJ, 1993, J RHEUMATOL, V20, P535
[2]
ASELTINE RH, 1995, MED CARE, V33, pAS67
[3]
BAYLEY KB, 1995, MED CARE, V33, pAS226
[5]
WHICH OUTCOME MEASURES SHOULD BE USED IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS - CLINICAL AND QUALITY-OF-LIFE MEASURES RESPONSIVENESS TO TREATMENT IN A RANDOMIZED CONTROLLED TRIAL
[J].
ARTHRITIS AND RHEUMATISM,
1995, 38 (11)
:1568-1580
[6]
CLEARY PD, 1988, INQUIRY-J HEALTH CAR, V25, P25
[7]
DEYO RA, 1984, HEALTH SERV RES, V19, P275
[8]
THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY CORE SET OF DISEASE-ACTIVITY MEASURES FOR RHEUMATOID-ARTHRITIS CLINICAL-TRIALS
[J].
ARTHRITIS AND RHEUMATISM,
1993, 36 (06)
:729-740
[9]
MEASURING RELEVANT CHANGE - AN EMERGING CHALLENGE IN RHEUMATOLOGIC CLINICAL-TRIALS
[J].
ARTHRITIS AND RHEUMATISM,
1995, 38 (08)
:1027-1030
[10]
A CRITICAL-APPRAISAL OF THE QUALITY OF QUALITY-OF-LIFE MEASUREMENTS
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1994, 272 (08)
:619-626